NCT04555798View on ClinicalTrials.gov

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Patients With Respiratory Failure and Shocked
Interventions
DRUG

Meropenem Injection

patients of both groups given meropenam 1 gram every 8 hours till we collect the sputum culture

DEVICE

A-V ECMO

Only patients of group B connected to A-V ECMO for two weeks

Trial Locations (1)

21944

King abd el Aziz specialist hospital, Ta'if

All Listed Sponsors
collaborator

King Abdul Aziz Specialist Hospital

NETWORK

lead

Mohamed Gaber Allam

NETWORK